givinostat

FDA Drug Profile — DUVYZAT

Drug Details

Generic Name
givinostat
Brand Names
DUVYZAT
Application Number
NDA217865
Sponsor
Italfarmaco SPA
NDC Codes
1
Dosage Forms
SUSPENSION
Routes
ORAL
Active Ingredients
GIVINOSTAT

Indications and Usage

1 INDICATIONS AND USAGE DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. DUVYZAT is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. ( 1 )